SAN FRANCISCO: Rowan University School of Osteopathic Medicine and Durin Technologies, Inc. has invented a blood test that can detect early stages of Alzheimer’s disease that is called the mild cognitive impairment (MCI) stage, with unparalleled accuracy.
A research team led by Dr. Robert Nagele conducted this new blood test on 236 participants. The result showed that test was accurate, sensitive and had rate of 100% in identifying subjects whose MCI was actually caused by an early stage of Alzheimer’s disease. An early stage of Alzheimer’s disease causes MCI to 60% of all MCI patients, while the rest of proportion of cases is caused by other factors that include vascular issues, drug side-effects and depression…